Clinical Trial Update: PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca [Phase 1]

View source ↗

Summary

A Phase I trial evaluating cetuximab (Erbitux) plus gemcitabine with radiation therapy for locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Gemzar (gemcitabine)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED